HIV News and Research

RSS

Fred Hutch’s new Evergreen Fund to promote commercialization of research into lifesaving therapies

Fred Hutchinson Cancer Research Center announced its first-ever grants from its newly established Evergreen Fund to spur researchers' efforts to advance bold ideas toward creating or partnering with a commercial entity.

28 Dec 2016

Einstein awarded more than $160 million NIH grant in federal fiscal year 2016

Investigators at Albert Einstein College of Medicine were awarded more than $160 million from the National Institutes of Health in federal fiscal year 2016.

28 Dec 2016

'Friendship Bench' approach holds potential to improve lives of people with mental health problems

Their offices are simple wooden seats, called Friendship Benches, located in the grounds of health clinics around Harare and other major cities in Zimbabwe.

28 Dec 2016

New study shows efficacy of Ebola vaccine in offering protection against disease

An experimental Ebola vaccine was highly protective against the deadly virus in a major trial in Guinea, according to a new study that included researchers from the University of Maryland School of Medicine.

26 Dec 2016

Gulf Breeze Recovery underscores importance of high-quality programs for treating opioid addiction

As opioid addiction hits record highs, Gulf Breeze Recovery, a Florida-based addiction recovery center, stresses the importance of high-quality, successful programs for treating addiction.

26 Dec 2016

Experimental Ebola vaccine offers high protection against deadly virus, reveals major trial

An experimental Ebola vaccine was highly protective against the deadly virus in a major trial in Guinea, according to results published today in The Lancet. The vaccine is the first to prevent infection from one of the most lethal known pathogens, and the findings add weight to early trial results published last year.

23 Dec 2016

Study highlights barriers to HIV care in sub-Saharan Africa

Barriers to diagnosis and lack of access to modern medications have combined to place caregivers and HIV-positive patients in sub-Saharan Africa between a rock and a hard place.

23 Dec 2016

Blocking protein that initiates immune response against viral infections may help combat HIV

In findings they call counterintuitive, a team of UCLA-led researchers suggests that blocking a protein, which is crucial to initiating the immune response against viral infections, may actually help combat HIV.

23 Dec 2016

Heart attack risk for people with HIV nearly 50% higher than predicted

Current methods to predict the risk of heart attack and stroke vastly underestimate the risk in individuals with HIV, which is nearly double that of the general population, reports a new Northwestern Medicine study.

21 Dec 2016

Fly study shows RNA pathway plays major role in normal health and longevity

Humans and other animals carry rogue sequences of DNA in their genomes called transposable elements. To prevent passing TEs to their offspring, they employ the piRNA pathway in their reproductive organs to block the elements from being active in their sperm and eggs.

21 Dec 2016

First large-scale clinical study of long-acting injectable HIV drug begins

The first large-scale clinical trial of a long-acting injectable drug for HIV prevention began today.

21 Dec 2016

Study finds chances for recovery of women with anorexia or bulimia nervosa

A study from Massachusetts General Hospital (MGH) investigators finds that, contrary to what is often believed, around two thirds of women with anorexia nervosa or bulimia nervosa will eventually recover from their eating disorders.

21 Dec 2016

Bionic pancreas system manages blood sugar levels in patients with type 1 diabetes living at home

The bionic pancreas system developed by Boston University investigators proved better than either conventional or sensor-augmented insulin pump therapy at managing blood sugar levels in patients with type 1 diabetes living at home, with no restrictions, over 11 days.

20 Dec 2016

How can we tackle antimicrobial resistance?

Antimicrobial resistance happens when bugs, like bacteria, fungi or viruses, change, or evolve, when they’re exposed to drugs, like antibiotics, antifungals, or antivirals. Bugs that develop antimicrobial resistance are sometimes referred to as ‘superbugs’.

20 Dec 2016

HIV News and Research

Fred Hutch’s new Evergreen Fund to promote commercialization of research into lifesaving therapies

Einstein awarded more than $160 million NIH grant in federal fiscal year 2016

'Friendship Bench' approach holds potential to improve lives of people with mental health problems

New study shows efficacy of Ebola vaccine in offering protection against disease

Gulf Breeze Recovery underscores importance of high-quality programs for treating opioid addiction

Experimental Ebola vaccine offers high protection against deadly virus, reveals major trial

Study highlights barriers to HIV care in sub-Saharan Africa

Blocking protein that initiates immune response against viral infections may help combat HIV

Heart attack risk for people with HIV nearly 50% higher than predicted

Fly study shows RNA pathway plays major role in normal health and longevity

First large-scale clinical study of long-acting injectable HIV drug begins

Study finds chances for recovery of women with anorexia or bulimia nervosa

Bionic pancreas system manages blood sugar levels in patients with type 1 diabetes living at home

How can we tackle antimicrobial resistance?

Researchers use CRISPR-based genetic screening to identify three promising HIV treatment targets

Combination therapy holds great promise to clear precancerous skin lesions

Penn researchers pinpoint some effective HIV drugs in causing neuronal damage

Retinoblastoma protein plays larger role in tumor suppression, study finds

Psychology researcher explores barriers deterring MSM from seeking information on STIs

O'Neill Institute, NMAC release first of two reports to help prevent HIV in communities of color

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Latest News